Friday, March 27, 2015

Supply Creates Its Own Demand: Capitalist Dream, Patient Nightmare

By Tara Pihn (Guest Blogger)

Pfizer's blockbuster Lipitor (generic name Atorvastatin) is a household name globally. It is considered to be among the most effective of all of the statins, a class of drugs that work in a similar way. Used to treat CVD, it is very effective in reducing cholesterol, a known villain in the war against heart disease.

Cholesterol is also, among other things, a building block for the body's natural ability to create testosterone. And testosterone, as we well know, is a key ingredient in male libido and sexual function. According to WebMD (citing a European clinical trial), statins may lower testosterone, libido resulting in erectile dysfunction.

That said, men suffering from CVD, and their lovers, should not worry because there are several ways to address the emergent issue.

For example, Depo-Testosterone is an injectable hormone (androgen) replacement used to treat men diagnosed with low testosterone (Low T), and, you guessed it, Pfizer's unit Pharmacia & Upjohn Co. currently market the medication.

Meanwhile, Pfizer also makes Viagra (I am pretty sure the reader has heard of this one) and according to their website "works for men with erectile dysfunction (ED) by increasing blood flow to the penis so you can get and keep an erection hard enough for sex".

Despite the criticism often heaped on Big Pharma, this brief article illustrates the hard work they are doing to ensure our good health. 

Saturday, March 14, 2015

Healthcare Roundtable Program on End of Life Care Held March 3

We had a great program on Tuesday, March 3, 2015.

For those of you who attended, thanks for being there. You were a great audience. Meanwhile, the panelists and moderator were stellar. Thanks also to the sponsors and host.

For those of you unable to attend, you were missed.

I hope you can all come to our June 2 program to be held at Vi at Aventura from 7.30-9:30 am. An official announcement with link to the registration page will be sent shortly.

To view the "Wrap Story" on the End of Life Care program, click HERE.

-Jeff Herschler